Minneapolis -- U.S. studies suggest certain antidepressant drugs known as selective serotonin reuptake inhibitors may cause increased bone loss in older men and women.
The medications, known as SSRIs, are used to treat depression by inhibiting the protein that transports serotonin -- a neurotransmitter involved in sleep and depression. Since serotonin has also been discovered in bone, it raises the possibility SSRIs may affect bone density and the risk of fracture.
SSRIs account for about 62 percent of antidepressant prescriptions in the United States.
Dr. Susan Diem and colleagues at the University of Minnesota studied 2,722 older women -- average age 78.5 years -- and found SSRI use may have a direct deleterious effect on bone loss.
In a related study, Dr. Elizabeth Haney and colleagues at the Oregon Health and Sciences University conducted a similar study with 5,995 men age 65 and older. The researchers also found men using SSRIs suffered from a lower hip bone density than did men who didn't use antidepressants.
Both studies appear in the journal Archives of Internal Medicine.
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.
Recent comments
19 hours 33 min ago
19 hours 35 min ago
3 days 7 hours ago
3 days 7 hours ago
3 days 8 hours ago
3 days 10 hours ago
4 days 7 hours ago
4 days 13 hours ago
4 days 13 hours ago
4 days 16 hours ago